论文信息 - A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD). - 字舞流文

A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD).

Tanja | L. Servais | V. Straub | M. Eagle | Isabel | Thomas | Ferreira | Amélie | O. Veldhuizen | Campion | M. Bertoli | Giles | Braakman | A. Labourkas | Voit | Moraux